Gene Query: RIMS2

Dataset Description Geneva Score
Ultracentifugation and nanoscale deterministic lateral displacement (nanoDLD) of samples for exRNA analysis 66.56
RNA-seq analysis of control and ZC3H18-depleted ovarian cancer cells 54.85
RNA expression analysis of neuroblastoma cell lines treated with epigenetic drugs 48.56
Treatment Paradigms for Retinal and Macular Diseases Using 3-D Retina Cultures Derived From Human Reporter Pluripotent Stem Cell Lines 43.2
Next Generation Sequencing Facilitates Quantitative Analysis of Retinoblastoma Transcriptomes 42.3
High-Throughput Drug Screening identifies Pazopanib and Clofilium tosylate as effective treatments for malignant rhabdoid tumors 32.66
TRIM28-Regulated Transposon Repression Is Required for Human Germline Competency and Not Primed or Naive Human Pluripotency 29.37
ARID1A loss impairs enhancer-mediated gene regulation and drives colon cancer in mice [HCT116_RNA-seq] 27.31
ARID1A loss impairs enhancer-mediated gene regulation and drives colon cancer in mice 27.31
Mutation independent activation of the Notch pathway is associated with Lapatinib resistance in Her2+ breast cancer cell lines 26.86
Analyzing the interactions of mRNAs, miRNAs, lncRNAs and circRNAs to predict competing endogenous RNA networks in glioblastoma 24.2
Single-cell RNA-seq reveals novel cell differentiation dynamics during human airway epithelium regeneration 24.01
Recovery and analysis of nascent RNA 22.63
The oncogenic BRD4-NUT chromatin regulator drives aberrant transcription within large topological domains 22.63
RNA m5C Methylation in breast cancer using MeRIP-Seq 22.18
Generation, transcriptome profiling, and functional validation of cone-enriched human retinal organoids 21.93
The mSWI/SNF ATPase module mediates subcomplex identity and non-catalytic targeting in SCCOHT [RNA-seq] 21.34
The ATPase module of mammalian SWI/SNF family complexes mediates subcomplex identity and catalytic activity-independent genomic targeting 21.34
Single-cell survey of human lymphatics unveils marked endothelial cell heterogeneity and mechanisms of homing for neutrophils 20.82
Inhibition of DNA methylation promotes breast tumor sensitivity to netrin-1 interference [RNA-Seq] 18.93
Inhibition of DNA methylation promotes breast tumor sensitivity to netrin-1 interference 18.93
Multiple mechanisms disrupt let-7 miRNA biogenesis and function in neuroblastoma [longRNA] 16.96
Post-transcriptional manipulation of TERC reverses molecular hallmarks of telomere disease 16.83
HDAC inhibition enhances the in vivo efficacy of MEK inhibitor therapy in uveal melanoma 16.79
Global Transcriptional analysis of human spinal cord and neocortical neuroepithelial stem (NES) cells 14.49
Epigenomic plasticity enables human pancreatic alpha to beta cell reprogramming 14.41
Comprehensive evaluation of differential gene expression analysis methods for RNA-seq data 13.51
Glioma Stem Cell Specific Super Enhancer Drives Polyunsaturated Fatty Acid Synthesis to Support EGFR Signaling 13.0
RNA-Seq study of Cell lines rendered resistant to idelalisib and ibrutinib 12.69
Circular RNAs in the mammalian brain are highly abundant, conserved, and dynamically expressed 12.64
Human iPSC-based Modeling of Late-Onset Disease using Progerin-induced Aging 12.46
RNA-seq of SOX5 overexpressing primary human neuronal progenitors 12.34
Genes regulated by soluble guanylyl cyclase in VCaP prostate cancer cells 12.28
Transcriptomic analysis reveals novel long non-coding RNAs critical for vertebrate development 11.45
Transcriptomic analysis reveals novel long non-coding RNAs critical for vertebrate development [RNA-Seq] 11.45
Global Bidirectional Transcription of the Epstein-Barr Virus Genome During Reactivation 11.42
Gene expression by high-throughput sequencing of T47D-MTVL human breast cancer cells upon H1.4 knock-down and multiple H1 variants 11.2
Distinct and shared functions of ALS-associated TDP-43, FUS, and TAF15 revealed by comprehensive multi-system integrative analyses [RNA-Seq_human] 11.18
Gene expression in mature and immature human ES-derived beta cells, and sorted beta-cells from adult islets 11.17
The Glioma-Infiltrating T Cell Receptor Repertoire 11.07
T47D RNA-seq and ChrRNA-seq data 10.94
Arginine citrullination at the C-terminal domain controls RNA Polymerase II transcription 10.94
Stably-paused genes revealed through inhibition of transcription initiation by the TFIIH inhibitor Triptolide 10.94
RNA sequencing reveals transcriptional changes after Hippo signaling activation in podocytes 10.68
A peninsular structure coordinates asynchronous differentiation with morphogenesis to generate pancreatic islets [bulk vs buds] 10.52
Muscleblind-like 1 suppresses breast cancer metastatic colonization and stabilizes metastasis suppressor transcripts 10.49
MBNL1-dependent modulation of gene expression in MDA-MB-231 breast cancer cells 10.49
SIRT7 Antagonizes TGF-β Signaling and Inhibits Breast Cancer Metastasis 10.48
Gene expression profiling in metabolically heterogeneous human lung tumors 10.4
The histone H3.3K27M mutation in pediatric glioma reprograms H3K27 methylation and gene expression 10.25
Codon usage optimization in pluripotent embryonic stem cells [RNA-seq] 10.21
A Brain Penetrant Mutant IDH1 Inhibitor Provides In Vivo Survival Benefit 10.14
CDK12 catalytic activity is rate-limiting for RNAPII processivity on core DNA replication genes and G1/S progression (3' RNA) 10.11
Single-cell RNA-Seq Investigation of Foveal and Peripheral Expression in the Human Retina 10.1
Temporal activation of NR5A2 and RARγ induce functional human naïve pluripotent state via modulating TGFβ pathway 10.02
To identify transcripts that are differentially expressed in the MYCN amplified vs MYCN non-amplified cell lines using Next Generation Sequencing 9.92
RNA-seq Profiles in Transcription elongation factors are in vivo-specific cancer dependencies in glioma 9.77
Transcription elongation factors are in vivo-specific cancer dependencies in glioma 9.77
H3.3K27M cooperates with p53 loss and Pdgfra gain in mouse embryonic neural progenitor cells to induce invasive high-grade gliomas 9.49
H3.3K27M cooperates with p53 loss and Pdgfra gain in mouse embryonic neural progenitor cells to induce invasive high-grade gliomas [Human RNA-Seq] 9.49
Transcriptome analysis of VCaP xenografts resistant to dual therapy with abiraterone and enzalutamide 8.9
Generation of induced neural stem cells from urine derived cells by synthetic mRNA 8.75
Epigenetic siRNA and chemical screens identify SETD8 inhibition as a new therapeutic strategy of p53 reactivation in high-risk Neuroblastoma. 8.75
Gene expression profiles of tumor-infiltrating CD8 T cells in hepatocellular carcinoma 8.65
The identification of RBM47 binding sites and RBM47-dependent alternative splicing events in brain metastatic breast cancer cells 8.63
Identification of alternatively spliced transcripts in brain metastatic derivatives of MDA-MB-231 breast cancer cells in response to RBM47 expression 8.63
MUC1-C represses the RASSF1A tumor suppressor and activated Kras signaling in human carcinoma cells 8.44
Neuronal brain region-specific DNA methylation and chromatin accessibility are associated with neuropsychiatric trait heritability 8.2
Neuronal brain region-specific DNA methylation and chromatin accessibility are associated with neuropsychiatric trait heritability [RNA-Seq] 8.2
RNA sequencing for PDX1, NGN3 and MAFA transduced iPSCs cell 8.2
DHX36 resolves G-rich structures in mRNA untranslated region to allow their translation [ChrRNA-seq] 8.19
Genome-wide RNA-sequencing (RNA-seq) of benign and malignant prostate cell lines without and with androgen (R1881) stimulation. 8.18
Truncation of LOC100288798 (SLC38A4-AS) lncRNA in human haploid KBM7 cell line 7.97
RNA Sequencing Facilitates Quantitative Analysis of Transcriptomes of H1, H1 derived APLNR+ cells, CD31+CD34+ cells and CD43+ cells during human early hematopoietic differentiation 7.92
Endogenous interaction profiling identifies DDX5 as an oncogenic coactivator of transcription factor Fra-1 [RNA-seq] 7.8
Endogenous interaction profiling identifies DDX5 as an oncogenic coactivator of transcription factor Fra-1 7.8
mRNA expression profiling in MDA-MB-231 (LM1) cells with a tet-incible MBD2 or p66α knock down, or treated with MBD2-targeting small molecule ABA or APC 7.78
Compared performance of Affymetrix HTA arrays and Illumina RNAseq for the analysis of tumours [RNA-seq] 7.72
Compared performance of Affymetrix HTA arrays and Illumina RNAseq for the analysis of tumours 7.72
Capturing the Interactome of Newly Transcribed RNA 7.71
Capturing the Interactome of Newly Transcribed RNA (RICK) 7.71
Expression profiling and occupancy after knockdown or over-expression of HFN1A or HNF4G in prostate cancer cells 7.7
Transcriptomic Analysis of Endothelial Cells from Fibrovascular Membranes in Proliferative Diabetic Retinopathy 7.53
RNA-seq analysis of melanoma and carcinoma cells expressing FOXQ1 7.35
Expression profiles of the four human major ectodermal lineages 7.21
HEXIM1 is induced by DHODH inhibition to suppress melanoma [Gro-Seq] 7.06
HEXIM1 is induced by DHODH inhibition to suppress melanoma 7.06
RNA-seq profiling of the human neutrophil genome during PMA- and E. coli encounter-induced activation 6.91
Human neutrophil genome during PMA- and E. coli encounter-induced activation 6.91
Human iPSC-derived microglia assume a primary microglia-like state after transplantation into the neonatal mouse brain [Single Cell RNAseq] 6.89
Transcriptomics analysis of enteroendocrine cells following vertical sleeve gastrectomy 6.89
Transcriptomics analysis of human jejunal enteroendocrine cells after vertical sleeve gastrectomy 6.89
Transcriptomic analysis of LSD1 6.85
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation [RNA-Seq rescue_SS] 6.68
Apoptotic endothelial cells release small extracellular vesicles loaded with immunostimulatory viral-like RNAs 6.62
RNA-seq of MDA-MB-231 cells with TET1 knockout 6.59
Transcriptome analysis of H9 hESC derived cerebral organoids 6.59
CDK4/6 inhibitors target SMARCA4-determined cyclin D1 deficiency in hypercalcemic small cell carcinoma of the ovary (I) 6.55
Large-scale epigenetic reprogramming is punctuated late during the evolution of pancreatic cancer progression [RNA-Seq] 6.53
Alteration of the microRNA network during the progression of Alzheimer’s disease 6.32
nELAVL HITS-CLIP in Alzheimer's Disease patients 6.21
Proteotranscriptomic profiling of potential E6AP targets in prostate cancer cells 5.92
Single-cell transcription profiling in KS1 patient iPSCs and NPCs 5.88
Self-organized amniogenesis by human pluripotent stem cells in a biomimetic implantation-like niche 5.85
Resistance to BET inhibitor leads to new therapeutic vulnerabilities in castration resistant prostate cancer 5.83
Rna-seq transcriptome data for insulin-GFP+ cells differentiated from NEUROD1 knock out and NEUROD1+/+ control human embryonic stem cells. 5.77
NEUROD1 dependent gene regulation in murine pancreatic endocrine cells and human stem cell derived insulin producing cells 5.77
FUS KO mRNA sequencing and anti-FUS RNA immunoprecipitation sequencing 5.71
The age and genomic integrity of neurons after cortical stroke in humans 5.61
PNET animal model: new insights (II) 5.61
Single-cell analysis reveals stochastic regulation of type I IFN production by plasmacytoid dendritic cells and identifies host-derived environmental cues as amplifier of type I IFN production 5.47
The multiple myeloma risk allele at 5q15 lowers ELL2 expression and increases ribosomal gene expression [ELL2 KO] 5.41
RNA-seq analysis of uveal melanoma cells treated with FR900359 5.4
Selective expansion of myeloid and NK cells in humanized mice yields human-like vaccine responses (Experiment 1: RNA-seq) 5.4
The effect of doxycycline-induced expression of host-cell-factor 2 (HCF-2) proteins on the global gene expression in HEK-293 cells 5.39
In vitro differentiation of human low threshold mechanoreceptive (LTMR) neurons from embryonic stem cells 5.28
circRNA-sequencing 5.24
Global transcript structure resolution of high gene density genomes through multi-platform data integration: Illumina RNA-Seq 5.15
The effects of U1 snRNA mutation in chronic lymphocytic leukemia cell lines 5.12
A compendium of promoter-centered long-range chromatin interactions in diverse human tissues and cell types 5.11
Transcriptomic analysis of ERR alpha orphan nuclear receptor 5.08
Combined Experimental and System-Level Analyses Reveal the Complex Regulatory Network of miR-124 during Human Neurogenesis [d7+d14] 5.07
Genome-wide CRISPR-Cas9 screen identifies druggable synthetic lethality between LSD1 and MTORC1 in MLL-translocated AML 5.03
Global Long Terminal Repeat activation participates in establishing the unique gene expression program of classical Hodgkin Lymphoma [RNA-Seq] 4.98
MYCL and EP400 are required for Max and MCPyV mediated gene activation 4.97
Gene expression profile in endometrial organoids cultured in normal follicular phase vs PCOS-like hormone profile 4.88
ZRANB2 and SYF2 mediated splicing programs converging on ECT2 are involved in breast cancer cell resistance to doxorubicin 4.88
Next Generation Sequencing Compares Effects of microRNA-9 perturbation in control and SZ hiPSC NPCs 4.88
Comprehensive Transcriptome Analysis of Cerebral Cavernous Malformation Across Multiple Species and Genotypes 4.87
Flura-seq identifies organ-specific adaptations in metastasis-initiating cells 4.83
HITS-CLIP analysis uncovers a link between the Kaposi's sarcoma associated herpesvirus ORF57 protein and host pre-mRNA metabolism 4.8
LMO1 Synergizes with MYCN to Promotes Neuroblastoma Initiation and Metastasis 4.77
Polysome-associated mRNA profiling of cancer cells in response to CXCL12 and IGF1 4.76
Total RNA sequencing of prospective axial stem cell cultures derived from human pluripotant stem cells 4.7
RNA-Seq following PCR-based sorting reveals rare cell transcriptional signatures 4.66
CRISPR-Cas9 combinatorial KO of epigenetic regulators in human ovarian cancer cells 4.61
Discovery of a Drug Candidate for GLIS3-Associated Diabetes 4.46
Modulation of mitochondrial DNA copy number to induce hepatocytic differentiation of human Amniotic Epithelial cells 4.38
NSD2 overexpression links drives clustered chromatin and transcriptional changes in a subset of insulated domains of insulated domains 4.33
Gene expression profiling of neural crest progenitor cultures derived from human embryonic stem cells carrying nonsense mutations in the Polycomb gene ASXL1 [HET] 4.29
Human islets of varying quality: the good, the (not so) bad and the ugly 4.27
Recapitulation of Human Neural Microenvironment Signatures in iPSC-Derived NPC 3D Differentiation 4.26
SLAM-seq defines direct gene-regulatory functions of the BRD4-MYC axis 4.25
SLAM-seq defines direct gene-regulatory functions of the BRD4-MYC axis [Quant-Seq] 4.25
Profiling in vivo Bone Lesion (IVBL) and Orthotopic tumors by Next Generation Sequencing 4.23
NGS based identification of GD2-positive tumor-specific phenotype for cancer diagnostics and therapy 4.21
Capturing the biology of mild versus severe disease in a pluripotent stem cell-based model of Familial Dysautonomia 4.19
Transcriptional dependencies in diffuse intrinsic pontine glioma 4.18
Multiple mechanisms disrupt let-7 miRNA biogenesis and function in neuroblastoma 4.17
Genome-wide detection of DNase I hypersensitive sites in single cells and FFPE tissue samples 4.13
Effect of 48h treatment with 100nM GSK2879552 on T-ALL cell lines HSB2 and RPMI8402 4.12
GATA3-mediated chromatin reprogramming in breast cancer cells 4.12
‘Naïve’ ESRRB+ iPSCs with the capacity for rapid neural differentiation 4.04
Selective expansion of myeloid and NK cells in humanized mice yields human-like vaccine responses (Experiment 2: scRNA-seq) 3.98
AKAP8 inhibits tumor metastasis by antagonizing EMT-associated RNA alternative splicing 3.98
A prostate cancer chromatin interaction map 3.93
Gene expression profile in breast cancer cells 3.92
Genome-wide profile of cJun and p27 and gene expression profile in breast cancer cells 3.92
Effect of selective glucocorticoid receptor modulation (SGRM) on gene expression in human prostate cancer cell lines 3.89
Identification of transcripts altered upon LIN-41 knockdown in human embryonic stem cells 3.89
Gene expression profiles of rescue with wild type or SUMO double mutant TRIM24 3.86
FUS mutant human motoneurons transcriptome analysis reveals altered pathways and impairment of microRNA function 3.86
Expression profile of HNF1A knockdown and overexpression in 22RV1 and LNCaP cells respectively 3.77
Melanoma therapeutic strategies that select against resistance by exploiting MYC-driven evolutionary convergence 3.77
ChIP-seq and RNA-seq from human lymphoma cell lines 3.7
RNA-seq data from human lymphoma cell lines 3.7
Essential Roles of SETD7 as Transcriptional Activator and Co-regulator of H3K36me in Cardiac Lineage Commitment 3.64
RNA-Seq from early time points in the kidney differentiation protocol 3.62
Non-coding and coding transcriptional profiles are significantly altered in pediatric Retinoblastoma tumors 3.61
High throughput characterization of the m6A demethylase FTO by CLIP and RNAseq 3.6
Transcriptome analysis revealed impaired cAMP responsiveness in PHF21A-deficient human cells 3.56
RNA-seq of SCLC PDX models treated with EP 3.55
The RNA helicase DDX6 regulates self-renewal and differentiation of human and mouse stem cells [RNA-Seq] 3.5
RNA-Seq of the corpus callosum from 12 individuals 3.49
Evaluation of RNA amplification and RNA-Seq library preparation protocols for spermatozoa RNA profiling 3.42
Derivation of kidney organoids from human pluripotent stem cells [RNA-Seq: Data Set 1] 3.39
Biochemical fractionation of HEK293 nuclei and RNA-seq of chromatin-associated and soluble-nuclear RNA 3.36
TT-Seq captures the human transient transcriptome 3.36
C9/ALS Human Embryonic Stem Cells and C9/ALS Induced Pluripotent Stem Cells 3.34
Transcriptome analysis of Zika infected neural stem cells 3.3
Zika infected neural stem cells 3.3
Widespread backtracking by RNA pol II is a major effector of gene activation, 5’ pause release, termination and transcription elongation rate 3.28
Targeted differentiation of regional ventral neuroprogenitors and related neuronal subtypes from human pluripotent stem cells 3.27
Analysis of active enhancers and direct androgen receptor target genes in VCaP prostate cancer cells 3.23
Genome wide expression change in LCC2 and MCF-7 cells 3.22
Loss of Nuclear TDP-43 Is Associated with Decondensation of LINE Retrotransposons [RNA-Seq] 3.21
Loss of Nuclear TDP-43 Is Associated with Decondensation of LINE Retrotransposons 3.21
Targeting Taxane-Platin Resistant Lung Cancers with JumonjiC Lysine Demethylase Inhibitors (RNA-Seq) 3.21
Targeting Taxane-Platin Resistant Lung Cancers with JumonjiC Lysine Demethylase Inhibitors 3.21
CD13 and ROR2 permit isolation of highly enriched cardiac mesoderm from differentiating human embryonic stem cells 3.16
Isolation of highly enriched cardiac mesoderm from differentiating human embryonic stem cells 3.16
Smad5 acts as an intracellular pH messenger and maintains bioenergetic homoeostasis 3.13
RNA-Seq comparative analysis of human neuroblastoma cells before and after their confrontation to the embryonic microenvironment 3.11
The LIN28B/let-7 axis is a novel therapeutic pathway in Multiple Myeloma 3.07
Gene expression profiles of ibrutinib-responsive and ibrutinib non-responsive cells in ERBB4 expressing cancer cell lines 3.07
RNA-Seq Samples of siTFE3 in 8988T PDA Cell Line to Investigate Transcriptional Control of the Autophagy-Lysosome System 3.06
Proteostasis by STUB1/HSP70 complex controls sensitivity to androgen receptor targeted therapy in advanced prostate cancer 3.05
Proteostasis by STUB1/HSP70 complex controls sensitivity to androgen receptor targeted therapy in advanced prostate cancer (RNA-Seq) 3.05
R430: A potent inbibitor of DNA and RNA viruses 3.04
Inducible three-factor direct reprogramming to nephron progenitors using piggyBac transposons 3.03
Genetic Tagging During Human Mesoderm Differentiation Reveals Tripotent Lateral Plate Mesodermal Progenitors 2.97
RNA-seq data of small cell carcinoma of the bladder (SCCB) /urothelial carcinoma (Non-SCCB) clinical samples, and bladder-PARCB cell lines 2.96
Derivation of kidney organoids from human pluripotent stem cells [RNA-Seq: Data Set 2] 2.96
Folate modulation induces chromosomal instability and higher proliferation of immortalized human keratinocytes 2.95
CD95L derived si- and shRNAs kill cancer cells through an RNAi mechanism by targeting survival genes [shL3.shR6.RNAseq.lg] 2.95
The Human Testis Cell Atlas via Single-cell RNA-seq 2.9
Transcriptome analysis of genetically matched human induced pluripotent stem cells disomic or trisomic for chromosome 21 2.87
Transcription-dependent control of stem cell self-renewal and differentiation by the splicing factor U2AF1 2.86
Reassessment of Exosome Composition 2.84
NKX2.2 2.83
RNA-Seq analysis of NKX2.2 knockdown in human pancreatic islets 2.83
Defining a microRNA-mRNA targetome for calcineurin inhibitor induced nephrotoxicity 2.83
Genome-wide transcriptome analysis of NIPBL iPSC and commited cardiomyoctes 2.79
Nuclear HNRNPA2B1 HITS-CLIP and RNA-seq 2.79
Mapping cis-regulatory chromatin contacts in neural cells links neuropsychiatric disorder risk variants to target genes 2.77
Mapping cis-regulatory chromatin contacts in neural cells links neuropsychiatric disorder risk variants to target genes [RNA-Seq] 2.77
Large-Scale Atlas of Mutant IDH1-Dependent Chromatin State Reprogramming, Reversibility, and Persistence [RNA-seq] 2.75
Large-Scale Atlas of Mutant IDH1-Dependent Chromatin State Reprogramming, Reversibility, and Persistence 2.75
Genetic disarray follows mutant KLF1-E325K expression in a congenital dyserythropoietic anemia patient 2.74
Whole Transcriptomic Sequencing of Metastatic Castration Resistant Prostate Cancer Samples 2.73
Universal alternative splicing of noncoding exons 2.71
Opposing Effects of Cyclooxygenase-2 (COX-2) on Estrogen Receptor β (ERβ) Response to 5α-reductase Inhibition in Prostate Epithelial Cells 2.71
Transcriptional Profiling of Werner Syndrome (WS) iPSC-derived MSC and the isogenic gene-edited controls 2.71
cKIT+ sorted cells from 57-137 day old fetal testes and ovaries 2.69
RNA-Seq of cKIT+ sorted cells from 53-137 day old fetal testes and ovaries and RNA-Seq of TRA-1-81+ H1 and UCLA1 hESCs. 2.69
Transcriptome analysis on TDP43 and SRSF3 downstream genes and binding RNAs in MDA-MB231 cells by Next Generation Sequencing 2.69
PAK4 suppresses RELB to prevent senescence-like growth arrest in breast cancer 2.68
Repurposing of promoters and enhancers during mammalian evolution 2.67
Poly(A)-specific ribonuclease (PARN) mediates 3' end maturation of the telomerase RNA component 2.66
Diverse AR-V7 cistromes in castration-resistant prostate cancer are governed by HoxB13 2.66
A single-cell atlas of the human cortex reveals drivers of transcriptional changes in Alzheimer’s disease in specific cell subpopulations 2.65
Knock-down of Ror1 in MDA-MB-231 cell line decreases cell invasiveness 2.63
A single-cell transcriptome atlas of the human pancreas 2.62
IL-21/type I interferon interplay regulates neutrophil-dependent innate immune responses to Staphylococcus aureus 2.6
Epigenome regulation during epidermal lineage commitment [ATAC-seq, RNA-seq] 2.59
Transcriptomic responses to Ivacaftor and prediction of Ivacaftor clinical responsiveness 2.59
Characterization of transcriptomics landscape in HUVEC cells exposed to oxidative stress (Total RNA) 2.58
RNA-Seq of LRRK2 G2019S Parkinson’s iPSC-derived astrocytes 2.57
The expression of genes encoding palmitoylated proteins in axonal and synaptic compartments is affected in CLN1/PPT1 transfected neuronal cells 2.55
Cell Type-Specific Chromatin Signatures Underline Regulatory DNA Elements in Human Induced Pluripotent Stem Cells and Somatic Cells 2.55
An interaction with Ewing's sarcoma breakpoint protein EWS defines the specific oncogenic mechanism of ETS factors rearranged in prostate cancer 2.54
DHX36 is the missing link to understand RNA G-quadruplex structures, mRNA stability, and translation [RNA-seq] 2.54
Triple vectors expand AAV transfer capacity in the retina 2.5
Bi-allelic Alteration and Dysregulation of the Hippo Pathway in Mucinous Tubular and Spindle Cell Carcinoma of the Kidney 2.5
The pause-initiation limit restricts transcription activation in human cells 2.49
ChIP-seq and RNA-seq analysis of KMT2D-silenced metastatic melanoma cells 2.49
The influence of PPFIA1 silencing to gene expression in breast carcinoma cell line and head and neck squamous cell carcinoma cell lines by RNA-sequencing in three dimensional collagen I 2.46
RNA-seq of cells with TET1 knockout 2.46
In vitro modeling of human germ cell development using pluripotent stem cells 2.46
Investigation into human Tra2 protein-dependent splicing in MDA-MB-231 cells using iCLIP and RNA-seq 2.45
An Argonaute phosphorylation cycle promotes microRNA-mediated silencing [polyA RNA-seq] 2.45
Loss of the Chr16p11.2 candidate gene QPRT leads to aberrant neuronal differentiation 2.45
DHX36 resolves G-rich structures in mRNA untranslated region to allow their translation [cPDS-RNA-seq] 2.43
Transcriptional profiling of healthy, eutopic and ectopic endometrial organoids 2.43
Modeling Familial Cancer with iPSC Approaches 2.43
Transcriptomics profiling of Alzheimer’s disease reveal novel molecular targets 2.42
Oncogenic Notch promotes long-range regulatory interactions within hyperconnected 3D cliques 2.41
a-synuclein accumulation in an iPSC derived model of early onset sporadic Parkinson’s Disease reveals novel drug targets 2.39
N6-methyladenosine (m6A) profiling of EndoC-bH1 cell line and RNA seq of Mettl14 knockout mice beta cell 2.38
Stranded RNA-seq were performed on total RNA following ribosomal RNAs depletion (Ribo-zero removal kit, illumina) for 3 brain , 8 IDHwt and 5 IDHmut glioma samples. 2.38
Single-cell RNA sequencing-based CRISPRi screening resolves molecular drivers of early human endoderm development [set 1] 2.38
C9orf72 Intermediate Repeats are Associated with Corticobasal Degeneration, Increased C9orf72 Expression and Disruption of Autophagy 2.37
Salmonella activation of STAT3 signaling by SarA effector promotes intracellular replication and production of IL-10 2.36
Gene expression profiles of 4-1BB+PD-1-high, 4-1BB-PD-1-high, and PD-1-int tumor-infiltrating CD8 T cells in hepatocellular carcinoma 2.35
HNF1A deficiency impairs β-cell fate, granule maturation and function 2.34
Carcinoma-astrocyte gap junctions promote brain metastasis by cytosolic dsDNA response transfer 2.31
Ectoderm specification of H1 human embryonic stem cells 2.3
Lipid Nanoparticle-Mediated Delivery of Anti-miR-17 Family Oligonucleotide Suppresses Hepatocellular Carcinoma Growth 2.29
mRNA Profiling of miR-17 family inhibition using TuD lentiviral vector in HepG2 and SK-Hep1 hepatocellular carcinoma cell lines [RNA-Seq] 2.29
Tumor suppressor SMARCB1 suppresses super-enhancers to govern hESC lineage determination 2.29
Transcriptome of iPSC-derived Neural Cells with Heterozygous Knockout in CHD8 2.28
Single cell analysis of HSV-1 infection reveals anti-viral and developmental programs are activated in distinct sub-populations with opposite outcomes 2.24
Medial Ganglionic Eminence and Cortical Organoids Model Human Brain Development and Interneuron Migration 2.24
Adaptation of the Kinome Promotes Resistance to BET Bromodomain Inhibitors in Ovarian Cancer 2.23
Prolyl Hydroxylase Substrate Adenylosuccinate Lyase Is An Oncogenic Driver In Triple Negative Breast Cancer 2.22
The role of CFTR in islet function 2.21
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability 2.18
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability (22RV1 RNA-seq) 2.18
Parkinson’s Disease Genetic Risk in a Midbrain Neuronal Cell Line 2.14
Transcriptomic Profiling of Developing Human Paraxial Mesoderm from 4.5-5 Weeks of Gestation Human Embryos 2.13
RNAseq data from SCCOHT1 and OVCAR8 ovarian cancer cells treated with BET inhibitors 2.12
Single Cell RNA-sequencing of cell types isolated by FACS from normal human prostates 2.12
Pharmacological Induction of a Progenitor State for the Efficient Expansion of Primary Human Hepatocytes 2.12
Altered expression of signaling pathways regulating neuronal excitability in hippocampal tissue of temporal lobe epilepsy patients with low and high seizure frequency 2.12
A Basal Stem Cell Signature Identifies Aggressive Prostate Cancer Phenotypes 2.11
Metastasis in triple-negative breast cancer 2.11
Functional and genomic characterization of a xenograft model system for the study of metastasis in triple-negative breast cancer. 2.11
H3K36 mutations promote sarcomagenesis through genome-wide remodeling of H3K36 and H3K27 methylation [RNA_Chondroblastoma_H3K36M_H3WT] 2.1
H3K36 mutations promote sarcomagenesis through genome-wide remodeling of H3K36 and H3K27 methylation 2.1
Gene expression profiling of neural crest progenitor cultures derived from human embryonic stem cells carrying nonsense mutations in the Polycomb gene ASXL1 [HOM] 2.1
Bach1 Regulates the Self-renewal and Mesendodermal Differentiation of Human Embryonic Stem Cells 2.07
Comprehensive analysis of microRNA expression in regionalized human neural progenitor cells reveals microRNA-10 as a caudalizing factor 2.03
The myelin protein PMP2 is regulated by SOX10 and drives melanoma cell invasion 2.01
Transcriptome data of temporal and cingulate cortex in the Rett syndrome brain 1.99
Differentially expressed genes during pancreatic bud differentiation in cellular aggregates 1.99
ETS family proteins bind glucocorticoid receptor: relevance for treatment of Ewing sarcoma 1.98
Multi-platform assessment of transcriptional profiling technologies utilizing a precise probe mapping methodology 1.98
ARID1A and ARID1B loss in HCT116 cells 1.98
Transcriptome analyses of human pancreatic islets and pseudoislets 1.97
Enriched retinal ganglion cells derived from human embryonic stem cells (RNA-seq) 1.96
Non-transmissible measles virus vector with segmented RNA genome establishes different types of iPSCs from hematopoietic cells 1.92
Identification of expressed and conserved human non-coding RNAs 1.92
Human optic chiasm from healthy controls and multiple sclerosis patients 1.91
Multiple sclerosis and EAE 1.91
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation 1.89
In vitro differentiation of human embryonic stem cells into ovarian follicle-like cells 1.89
Transcriptomic analysis of human iPS cells derived from fragile X syndrome patients during neural differentiation 1.88
Loss of ANCO1 repression of AIB1/YAP drives breast cancer progression 1.86
Identification of miRNA signatures during the differentiation of hESCs into retinal pigment epithelial cells 1.85
Identification of novel recurrent ETV6-IGH fusions in primary central nervous system lymphoma using high throughput RNA sequencing 1.85
Deciphering H3K4me3 Broad Domains Associated With Gene Regulatory Networks and Conserved Epigenomic Landscapes in the Human Brain 1.84
Deciphering H3K4me3 Broad Domains Associated With Gene Regulatory Networks and Conserved Epigenomic Landscapes in the Human Brain [RNA-Seq] 1.84
ML29755 RNA-seq data 1.82
Identification of Atrial Fibrillation associated genes and functional non-coding variants 1.8
Increased Neanderthal ancestry in genomic regions associated with lipid catabolism in contemporary Europeans 1.79
HSB-2 cells stably expressing LDB1 or mutant LDB1 proteins 1.77
Distinct structural classes of activating FOXA1 alterations in prostate cancer progression 1.77
Distinct structural classes of activating FOXA1 alterations in prostate cancer progression [RNA-Seq] 1.77
Pseudotime Ordering of Single Human Beta-Cells Reveals States of Insulin Production and Unfolded Protein Response 1.76
Identification of a LIF-responsive replication-competent human β cell 1.76
Identification of long noncoding RNAs regulated by p53 1.76
Extracellular matrix hydrogel derived from decellularized tissues enables endoderm organoids culture 1.76
Priming mobilization of hair follicle stem cells triggers permanent loss of regeneration after alkylating chemotherapy 1.76
Nucleotide excision repair capacity increases during differentiation of human embryonic carcinoma cells into neurons and muscle cells 1.75
Genome-Wide Specificity of DNA-Binding, Gene Regulation, and Chromatin Remodeling by TALE- and CRISPR/Cas9-Based Transcription Factors 1.74
Noncoding regions are the main source of targetable tumor-specific antigens 1.72
Gene expressions of H9s in different culture systems 1.71
Sex-specific gene expression differences are evident in human embryonic stem cells and during in vitro differentiation of human placental progenitor cells 1.7
Analysis of human, chimpanzee, macaque and mouse tissue transcriptomes using Next Generation Sequencing 1.69
LINE-2 transposable elements are a source of functional human microRNAs and target sites 1.66
Total RNAseq of human putamen and caudate nucleus tissues in healthy control and Bipolar Disorder individuals 1.64
High-throughput single cell transcriptome analysis and CRISPR screen identify key β cell-specific disease genes 1.61
Global gene expression profiles of cardiac progenitors differentiated from human pluripotent stem cells in 3D culture under simulated microgravity 1.6
Biomarkers of Cavernous Angioma with Symptomatic Hemorrhage (CASH) [RNA-seq] 1.58
Biomarkers of Cavernous Angioma with Symptomatic Hemorrhage (CASH) 1.58
RNA sequencing, chromatin accesibility and ChIP seq analysis of BAP1 -/- human liver organoids 1.57
Sirt6 Oncogene Mediates PI3K/Akt Signaling Activation in Diffuse Large B-Cell Lymphoma 1.55
Estrogen-independent molecular actions of mutant estrogen receptor alpha in endometrial cancer [RNA-seq] 1.54
Estrogen-independent molecular actions of mutant estrogen receptor alpha in endometrial cancer 1.54
Activation of neuronal genes via LINE-1 elements upon global DNA demethylation in human neural progenitors 1.5
B-cell activating factor (BAFF) stimulation of Burkitt Lymphoma cell line [RNA-Seq] 1.47
B-cell activating factor (BAFF) stimulation of Burkitt Lymphoma cell line 1.47
CHCHD2 gene KO effect in iPSC drived motor neurons 1.47
Mapping of DHT-responsive or -independent AR-binding sites induced by activated Src in prostate cancer cell lines 1.46
Mapping of DHT-responsive or -independent AR-binding sites induced by activated Src in prostate cancer cell lines [RNA-seq] 1.46
RNA-sequencing of bulk CD19+ Thymic B cells from mice and humans 1.44
RNA-sequencing of bulk CD19+ Thymic B cells from young (3 month - 4 year) and old (42 - 61 years) humans 1.44
Neonatal and adult human testis defined at the single-cell level 1.44
Human germ cell formation in xenotransplants of induced pluripotent stem cells carrying X chromosome aneuploidies 1.43
RNA-Seq characterization of human H1-derived NPC differentiation timecourse 1.41
Comparing effects of perfusion and hydrostatic pressure on human chondrocytes using gene profiles 1.4
Transcriptional profiling of microglia; current state of the art and future perspectives 1.4
Transcriptional regulation in pluripotent stem cells by Methyl CpG binding protein 2 (MeCP2) 1.38
Transcriptomic profiling of cleavage-resistant RIPK1 induced autoinflammation syndrome patients 1.37
TT-seq captures simultaneous activation of eRNAs and promoters during T cell activation 1.37
Genome Wide Chromatin Mapping of accessibility (ATAC-seq) and H3K27ac histone modifications in CD56bright and CD56dim natural killer cells 1.31
Downregulation of LATS kinases alters p53 to promote cell migration 1.29
Global Long Terminal Repeat activation participates in establishing the unique gene expression program of classical Hodgkin Lymphoma [Primary RNA-Seq] 1.26
Transcriptome profiling identified a 3-lncRNA regulatory network in transthyretin against glucose induced hRECs dysfunction 1.25
RNA-sequencing of tamoxifen-resistant and -sensitive breast cancer cell lines. 1.22
RNA-Seq of cKIT+ sorted cells from 16-16.5 week old fetal testes and ovaries and RNA-Seq of TRA-1-60+ H1 hESCs 1.21
Activity-dependent transcriptional changes in human neurons 1.19
Entrectinib Resistance in a Neuroblastoma Xenograft Model 1.19
Propargite, an environmental chemical, interacts with GWAS identified diabetes genes to impact human pancreatic β-cell death 1.18
TNFα Signaling Exposes Latent Estrogen Receptor Binding Sites in Breast Cancer Cells 1.16
TNFα Signaling Exposes Latent Estrogen Receptor Binding Sites in Breast Cancer Cells [GRO-seq] 1.16
Comparing oestrogen-responsive genes in endometrial and breast cancer cell lines 1.16
Comparison of small cell lung cancer PDX model FHSC04 for response to LSD1 inhibitor RG6016/ORY1001 1.15
Long noncoding RNA LNMAT1 promotes lymphatic metastasis in bladder cancer 1.13
Human embryonic stem cell, chimpanzee induced pluripotent stem cell, orangutan induced pluripotent stem cell, rhesus embryonic stem cell, and their derived cortical organoid RNA-seq 1.12
Transcriptomic analysis of frontal fibrosing alopecia 1.11
Functional Haploid Human Oocytes Generated from Polar Body Genomes (RNA-Seq) 1.1
Functional Haploid Human Oocytes Generated from Polar Body Genomes 1.1
Disease Model of GATA4 Mutation Reveals Transcription Factor Cooperativity in Human Cardiogenesis 1.09
Disease Model of GATA4 Mutation Reveals Transcription Factor Cooperativity in Human Cardiogenesis [RNA-Seq] 1.09
RNA sequencing of T-ALL (COG study) 1.09
Analyses of T-ALL (COG study) 1.09
RNA sequencing of CACO-2 cells incubated with bifidobacteria grown on human milk oligosaccharides. 1.07
Transcriptome sequencing reveals aberrant alternative splicing in Huntington's disease 1.06
Transcriptome profiling of self-renewing hESCs and multipotent mesoderm progenitor cells as a function of substrate stiffness 1.03
Estrogen Receptor Beta Impacts Hormone-Induced Alternative mRNA Splicing in Breast Cancer Cells 1.02
Impact of library preparation on downstream analysis and interpretation of RNA-seq data: comparison between Illumina PolyA and NuGEN Ovation protocol 1.02
RNA-seq data 0.98
RNA sequencing for lncRNA, miRNA and mRNA expression analysis in human laryngeal cancer 0.97
Epigenome regulation during epidermal lineage commitment 0.96
Intrinsic histone acetyltransferase activity of BRD4 is responsible for nucleosome eviction and transcriptional activation 0.95
Profiling gene expression changes in ovarian cancer cells seeded on 3D organotypic culture of omentum 0.95
RNA-seq of overgrown interscapular adipose tissue with biallelic MFN2 mutations 0.95
H9-hESC derived human neural stem cells with combinations of mutant IDH1-R132H overexpression, P53 shRNA knockdown and/or ATRX shRNA knockdown 0.93
RNA-seq of H9-hESC derived human neural stem cells with combinations of mutant IDH1-R132H overexpression, P53 shRNA knockdown and/or ATRX shRNA knockdown 0.93
Single cell transcriptomics analysis of induced pluripotent stem cell-derived cortical neurons reveals frequent dual layer identity 0.92
Gene expression analysis of human haploid cells (HAP1) depleted of SMARCB1 and SMARCA4 0.91
CRISPR-mediated deletion of prostate cancer risk-associated CTCF loop anchors identifies repressive chromatin loops 0.91
Time series total RNA sequencing of a differentiation of human embryonic stem cells towards trophoblast lineage 0.91
Brain organoids reproducibly generate the cellular diversity of the human cerebral cortex 0.89
RNA sequencing analysis of selumetinib-resistant CRC cells lines 0.89
Transcriptional Profiling of CENPA-Depleted Prostate Cancer Cell Lines 0.89
CENPA-Bound Genes and Transcriptional Profiling of CENPA-Depleted Prostate Cancer Cells 0.89
Interphase condensins regulate ligand-depedent enhancer activation (GRO-seq) 0.87
Interphase condensins regulate ligand-depedent enhancer activation 0.87
Transcriptome-wide discovery of microRNA binding sites in human brain by Ago2 HITS-CLIP 0.86
Comparison of 7 small cell lung cancer PDX models, cultured ex vivo, for response to LSD1 inhibitor RG6016/ORY1001 0.85
Whole blood stabilization for the microfluidic isolation and molecular characterization of circulating tumor cells 0.83
Global host gene expression changes in KSHV+ PEL cells upon KSHV reactivation 0.83
Next Generation Sequencing Analysis of human embryonic stem cells derived MESP1-mTomato reporter cells 0.82
Stretch-Enhancers Delineate Disease-Associated Regulatory Nodes in T Cells 0.82
Canonical and non-canonical regulatory roles of androgen receptor variant 7 in prostate cancer 0.82
Myc activation coordinates gene transcription and protein translation responses 0.82
RNA-seq in neurons derived from iPSCs in controls and patients with schizophrenia and 22q11 del 0.81
Distinct roles of cohesin-SA1 and cohesin-SA2 in 3D chromosome organization  0.81
CHCHD10 gene KO effect in iPSC drived motor neurons 0.8
The Molecular Dissection of the Oncogenic Role of ETS1 in the Mesenchymal Subtypes of Head and Neck Squamous Cell Carcinoma [RNA-seq Cell lines] 0.78
CHD1 loss sensitizes prostate cancer to DNA damaging therapy by promoting error-prone double-strand break repair 0.77
Radiation enhances melanoma response to immunotherapeutic and synergizes with benzodiazepines to promote improved anti-tumor activity 0.76
Age-Related Gene Expression Changes in Prostate Cancer Patients [RNA-Seq] 0.74
Age-Related Gene Expression Changes in Prostate Cancer Patients 0.74
Long non-coding RNA expression profile associated with malignant progression of oral submucous fibrosis 0.72
Neuronal deletion of Gtf2i, associated with Williams syndrome, causes behavioural and myelin alterations rescuable by a remyelinating drug 0.71
Neuronal deletion of Gtf2i, associated with Williams syndrome, causes behavioural and myelin alterations rescuable by a remyelinating drug [human] 0.71
Genome-wide mapping of TEL-AML1 targets in acute leukemia 0.71
Gene expression profiles of PD1-high, PD1-intermediate, and PD1-negative tumor-infiltrating CD8 T cells in hepatocellular carcinoma 0.7
Transcriptomes of iPSC-derived and post-mortum Hypothalamus Neurons from obese and control donors 0.7
Single-Cell reconstruction of differentiation trajectory reveals essential dynamics in human cardiac lineage commitment 0.7
STX4 Over-Expression in Human islets 0.67
Human Pancreatic Islets Expressing HNF1A Variant Have Defective β cell Transcriptional Regulatory Networks 0.66
circNFIB suppresses lymphatic metastasis of pancreatic cancer 0.66
Critical role for Lymphocytes in Producing FLT3LG in Tumors and Driving Checkpoint Therapy-Receptive Immune Microenvironments 0.66
Deep sequencing of transcript levels in pluripotent stem cells and their differentiated derivatives in all three germ layers 0.66
RNA seq analysis of human macrophages after treatment of glimepiride versus empagliflozin. 0.66
Next Generation Sequencing Facilitates Quantitative Analysis of mesoderm posterior bHLH transcription factor 1(MESP1)+ and MESP1- cells' Transcriptomes 0.62
mRNA sequencing of oropharyngeal cancer cell lines 0.62
RNA sequencing of prostate cancer and normal tissue from African Americans and European Americans 0.62
Antiviral innate immunity of hepatitis C virus-infected stem cell-derived hepatocytes 0.62
Targeting miR-155 restores abnormal microglia and attenuates disease in SOD1 mice 0.61
miR-155 plays a crucial role in ALS and is an immune therapeutic target [RNA-Seq] 0.61
The Dynamic Epigenetic Landscape of the Retina During Development, Reprogramming, and Tumorigenesis 0.61
The Dynamic Epigenetic Landscape of the Retina During Development, Reprogramming, and Tumorigenesis [RNA-Seq_Hs] 0.61
SF3B1 Degron knockdown RNA-seq 0.61
RNA-Seq of human PDA cell lines transfected with control siRNA or Pdx1 siRNA 0.61
RNA-Seq with and without RNase treatment in PCa cell lines 0.56
The DNA methylation landscape of human melanoma 0.56
The DNA methylation landscape of human melanoma [RNA-Seq] 0.56
4C-seq of insulin promoter, knockdown of INS promoter activity and Genome-wide maps of chromatin state in EndoC-βH1 Cells 0.56
Viral shRNA Knockdown of INS Promotor Activity in EndoC-βH1 Cells  0.56
Illumina HiSeq Sequencing on Breast cancer PDX samples 0.52
RNAseq analysis of ruxolitinib treated breast cancers 0.5
Global transcriptome analysis in the MYCN-amplified neuroblastoma cell line IMR5-75 upon inducible MYCN-knockdown 0.49
BioProject PRJNA381064: Convergent origination of a Drosophila-like dosage compensation mechanism in a reptile lineage (Gene expression profiling in several tetrapod species, bulk tissue RNA-seq) 0.48
Leucegene: ALL sequencing 0.47
RNA-Seq and ChIP-Seq reveals SQSTM1/p62 as a key mediator of JunB suppression of NF-kB-dependent inflammation 0.46
JunB control of keratinocyte-mediated inflammation [RNA-seq] 0.46
The WNT target SP5 negatively regulates WNT transcriptional programs in human pluripotent stem cells 0.44
Transcriptome landscape of HeLa response upon triamcinolone acetonide 0.43
Response of triple negative breast cancer to BAZ2A/B inhibition and BET bromodomain inhibition alone and in combination 0.42
Characterization of the Merkel cell carcinoma miRNome 0.41
The phosphatidylinositol 3-kinase pathway as a potential therapeutic target in bladder cancer 0.41
Transcriptome-wide discovery of microRNA binding sites in human brain by Ago2 HITS-CLIP [Ago2-miRNA-target mRNA complexes] 0.4
RUVBL1/RUVBL2 ATPase Activity Drives PAQosome Maturation, DNA Replication and Radioresistance in Lung Cancer 0.4
Human Tfh cell RNA bulk sequencing 0.39
The RNA helicase DDX6 regulates self-renewal and differentiation of human and mouse stem cells [RNA-seq] 0.38
Dynamic gene expression in T-ALL following treatment and release of gamma-secretase inhibition [GRO-Seq] 0.38
Hyper-excitability of Neurons generated from Patients with Bipolar Disorder 0.35
Gene expression for surgically treated pancreatic cancer after one neoadjuvant vaccine dose 0.34
Genome-wide RNA-sequencing of human islets 48 hour after transduction with adenoviruses expressing either GFP (control), or histone chaperone ASF1B. 0.33
Expression profiling by RNA-Seq of breast cancer samples from patients in walnut-consuming and control groups 0.32
Transcriptomic profile of T cell acute lymphoblastic leukemia (T-ALL) cell from patients in CHCQMU 0.31
Recurrent alterations of TNFAIP3 (A20) in T-cell large granular lymphocytic leukemia 0.29
Global transcriptome analysis of WT versus HEB-/- hESCs 0.27
Critical role of transient activation of human endogenous retroviruses during reprogramming toward pluripotency (RNA-Seq) 0.27
Critical role of transient activation of human endogenous retroviruses during reprogramming toward pluripotency 0.27
Stapled peptide inhibitors of RAB25 target context-specific phenotypes in cancer 0.26
Transcriptome Analysis Reveals Distinct Responses to Physiologic versus Toxic Manganese Exposure in Human Neuroblastoma Cells 0.26
WNT signaling memory is required for ACTIVIN to function as a morphogen 0.26
ALS implicated protein TDP-43 sustains levels of STMN2 a mediator of motor neuron growth and repair 0.25
mRNAseq of Huntington's disease and control patient iPSC-derived brain microvascular endothelial cells 0.24
ELAVL2-regulated transcriptional networks in human neurons link atlernative splicing, autism and human neocortical evolution 0.23
Influenza Vaccination Primes Human Myeloid Cell Cytokine Secretion and Natural Killer Cell Function 0.22
Pancreatic Beta Cell Enhancers Regulate Rhythmic Transcription of Exocyst Triggering and Diabetes 0.21
Genome-wide Circadian Control of Transcription at Active Enhancers Regulates Insulin Secretion and Diabetes Risk 0.21
Integrated Multi-omic Analysis of Esthesioneuroblastomas Identifies Two Subgroups Linked to Cell Ontogeny 0.19
5hmC dynamically correlated with enhancer's activities during hES-to-Pancreatic endoderm cell differentiation (RNA-Seq) 0.19
5hmC dynamically correlated with enhancer's activities during hES-to-Pancreatic endoderm cell differentiation 0.19
α Cell Function and Gene Expression Are Compromised in Type 1 Diabetes 0.17
Transcriptomic profile of intestinal epithelial cells obtained from ileal endoscopic biopsies from newly-diagnosed, pediatric Crohn's disease patients and healthy controls. 0.16
LncRNA DEANR1 facilitates human endoderm differentiation by activating FOXA2 expression 0.16
Analysis of human ES cell differentiation establishes that the dominant isoforms of the lncRNAs RMST and FIRRE are circular 0.15
Transcriptomic Alterations in Lung Adenocarcinoma Unveil New Mechanisms Targeted by the TBX2 Subfamily of Tumor Suppressor Genes 0.13
UBE3A-mediated regulation of imprinted genes and epigenome-wide marks in human neurons 0.1
Engineered Nanointerfaces for Microfluidic Isolation and Molecular Profiling of Tumor-specific Extracellular Vesicles 0.09
Ex vivo Dynamics of Human Glioblastoma Cells in a Microvasculature-on-a-Chip System Correlates with Tumor Heterogeneity and Subtypes 0.09
The RNA-binding protein RBM47 suppresses metastatic breast cancer progression 0.09
Coordinated regulation of synthesis and stability of RNA during the acute TNF-induced proinflammatory response 0.06
single cell RNA-seq from Purkinje cell (ENCSR888LYA) 0.04
RNA-sequencing of the brain transcriptome implicates dysregulation of neuroplasticity, circadian rhythms, and GTPase binding in bipolar disorder 0.03
hNSCs siRNA NOVA2 0.03
Alternative classification of glioblastoma based on BUB1B-inhibition sensitivity 0.03
THZ1 targeting CDK7 suppresses STAT transcriptional activity and sensitizes T-cell lymphomas to BCL2 inhibitors 0.01
Aberrant expression profile of lncRNA and mRNA in dilated cardiomyopathy by RNA-sequence 0.0
UTX and 53BP1 co-regulate genetic programs for neural differentiation of human embryonic stem cells [RNA-seq] 0.0
UTX and 53BP1 co-regulate genetic programs for neural differentiation of human embryonic stem cells 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation